ATE425764T1 - Verwendung von igf-1 allein oder kombiniert mit dem wachstumsfaktor zur stimulierung des wachstums - Google Patents
Verwendung von igf-1 allein oder kombiniert mit dem wachstumsfaktor zur stimulierung des wachstumsInfo
- Publication number
- ATE425764T1 ATE425764T1 AT99123825T AT99123825T ATE425764T1 AT E425764 T1 ATE425764 T1 AT E425764T1 AT 99123825 T AT99123825 T AT 99123825T AT 99123825 T AT99123825 T AT 99123825T AT E425764 T1 ATE425764 T1 AT E425764T1
- Authority
- AT
- Austria
- Prior art keywords
- hormone
- binding protein
- growth
- bound
- lifa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/615,538 US5210017A (en) | 1990-11-19 | 1990-11-19 | Ligand-mediated immunofunctional hormone binding protein assay method |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE425764T1 true ATE425764T1 (de) | 2009-04-15 |
Family
ID=24465822
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95110334T ATE213165T1 (de) | 1990-11-19 | 1991-11-19 | Pharmazeutische zusammensetzung enthaltend wachstumshormon und wachstumshormon- bindungsprotein |
AT99123825T ATE425764T1 (de) | 1990-11-19 | 1991-11-19 | Verwendung von igf-1 allein oder kombiniert mit dem wachstumsfaktor zur stimulierung des wachstums |
AT92901281T ATE138739T1 (de) | 1990-11-19 | 1991-11-19 | Durch den liganden vermitteltes immunofunktionelles verfahren zur bestimmung hormonbindender proteine |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95110334T ATE213165T1 (de) | 1990-11-19 | 1991-11-19 | Pharmazeutische zusammensetzung enthaltend wachstumshormon und wachstumshormon- bindungsprotein |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92901281T ATE138739T1 (de) | 1990-11-19 | 1991-11-19 | Durch den liganden vermitteltes immunofunktionelles verfahren zur bestimmung hormonbindender proteine |
Country Status (12)
Country | Link |
---|---|
US (1) | US5210017A (de) |
EP (3) | EP0995445B1 (de) |
JP (2) | JP2977280B2 (de) |
AT (3) | ATE213165T1 (de) |
AU (1) | AU657109B2 (de) |
CA (1) | CA2093927C (de) |
DE (3) | DE69133614D1 (de) |
DK (3) | DK0995445T3 (de) |
ES (3) | ES2324322T3 (de) |
GR (1) | GR3020505T3 (de) |
HK (1) | HK1007351A1 (de) |
WO (1) | WO1992008985A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866350A (en) * | 1985-03-19 | 1999-02-02 | Helen Hwai-An Lee | Method for the immunological determination of a biological material in a sample |
US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
US5593844A (en) * | 1990-11-19 | 1997-01-14 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US6326154B1 (en) * | 1990-11-19 | 2001-12-04 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US5464757A (en) * | 1991-01-15 | 1995-11-07 | The Salk Institute For Biological Studies | DNA encoding CRF binding protein |
DK0955062T3 (da) * | 1992-07-31 | 2007-09-17 | Genentech Inc | Vandig formulering indeholdende humant væksthormon |
US6087188A (en) * | 1992-11-13 | 2000-07-11 | Alk A/S | Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand |
JPH08500740A (ja) * | 1993-06-25 | 1996-01-30 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | リポタンパク質関連ホスホリパーゼa▲下2▼、その阻害剤および診断および治療におけるその使用 |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
US20030069177A1 (en) | 2000-05-16 | 2003-04-10 | Genentech, Inc. | Method for treating cartilage disorders |
EP1141014B1 (de) * | 1999-01-06 | 2004-12-08 | Genentech, Inc. | Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i) |
US7497827B2 (en) | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7108993B2 (en) * | 2002-07-19 | 2006-09-19 | Bayer Healthcare Llc | Use of dual conjugated labels in the elimination of serum interference in immunochromatographic assays |
SE0300959D0 (sv) * | 2002-12-19 | 2003-04-02 | Pharmacia Ab | Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
PT2274978E (pt) | 2003-09-12 | 2015-07-09 | Ipsen Biopharmaceuticals Inc | Métodos para tratamento da deficiência do fator de crescimento de tipo insulina i (igf-i) |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE263537C (de) * | ||||
NL7501215A (nl) * | 1975-02-01 | 1976-08-03 | Akzo Nv | Methode voor het aantonen en bepalen van een antigeen of antilichaam. |
US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4476228A (en) * | 1982-11-08 | 1984-10-09 | Abbott Laboratories | Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques |
US4622293A (en) * | 1983-07-05 | 1986-11-11 | Miles Laboratories, Inc. | Iodothyronine immunoassays employing HMS as TBP blocking agent |
US4594327A (en) * | 1983-11-02 | 1986-06-10 | Syntex (U.S.A.) Inc. | Assay method for whole blood samples |
AU3934085A (en) * | 1984-01-30 | 1985-08-09 | Icrf Patents Ltd. | Improvements relating to growth factors |
US4737456A (en) * | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
JPS63273496A (ja) * | 1987-05-01 | 1988-11-10 | Sumitomo Pharmaceut Co Ltd | モノクロ−ナル抗体、ハイブリド−マおよびヒト成長ホルモン測定方法 |
DD263537A1 (de) * | 1987-09-01 | 1989-01-04 | Akad Wissenschaften Ddr | Verfahren zur herstellung von monoklonalen antikoerpern gegen humanes wachstumshormon |
US4956302A (en) * | 1987-09-11 | 1990-09-11 | Abbott Laboratories | Lateral flow chromatographic binding assay device |
GB2233091B (en) * | 1988-01-28 | 1992-05-27 | Du Pont | Immunoassays using monoclonal antibodies directed against natural binding proteins |
DK131988A (da) * | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
ATE132164T1 (de) * | 1988-04-12 | 1996-01-15 | Amgen Boulder Inc | Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors |
WO1990000569A1 (en) * | 1988-07-15 | 1990-01-25 | Central Sydney Area Health Service | Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
GB8826451D0 (en) * | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
EP0429586B1 (de) * | 1989-06-09 | 1995-08-02 | Gropep Pty. Ltd. | Wachstumshormonfusionsproteine |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
-
1990
- 1990-11-19 US US07/615,538 patent/US5210017A/en not_active Expired - Lifetime
-
1991
- 1991-11-19 DE DE69133614T patent/DE69133614D1/de not_active Expired - Lifetime
- 1991-11-19 AU AU91067/91A patent/AU657109B2/en not_active Expired
- 1991-11-19 WO PCT/US1991/008664 patent/WO1992008985A2/en active IP Right Grant
- 1991-11-19 ES ES99123825T patent/ES2324322T3/es not_active Expired - Lifetime
- 1991-11-19 DK DK99123825T patent/DK0995445T3/da active
- 1991-11-19 AT AT95110334T patent/ATE213165T1/de not_active IP Right Cessation
- 1991-11-19 DK DK92901281.3T patent/DK0558647T3/da active
- 1991-11-19 EP EP99123825A patent/EP0995445B1/de not_active Expired - Lifetime
- 1991-11-19 JP JP4501539A patent/JP2977280B2/ja not_active Expired - Lifetime
- 1991-11-19 DE DE69119911T patent/DE69119911T2/de not_active Expired - Lifetime
- 1991-11-19 EP EP92901281A patent/EP0558647B1/de not_active Expired - Lifetime
- 1991-11-19 EP EP95110334A patent/EP0681842B1/de not_active Expired - Lifetime
- 1991-11-19 CA CA002093927A patent/CA2093927C/en not_active Expired - Lifetime
- 1991-11-19 ES ES92901281T patent/ES2090598T3/es not_active Expired - Lifetime
- 1991-11-19 AT AT99123825T patent/ATE425764T1/de not_active IP Right Cessation
- 1991-11-19 ES ES95110334T patent/ES2171478T3/es not_active Expired - Lifetime
- 1991-11-19 DK DK95110334T patent/DK0681842T3/da active
- 1991-11-19 DE DE69132931T patent/DE69132931T2/de not_active Expired - Lifetime
- 1991-11-19 AT AT92901281T patent/ATE138739T1/de not_active IP Right Cessation
-
1996
- 1996-07-10 GR GR960401874T patent/GR3020505T3/el unknown
-
1998
- 1998-06-25 HK HK98106559A patent/HK1007351A1/xx not_active IP Right Cessation
-
1999
- 1999-05-10 JP JP12859899A patent/JP3159966B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69119911D1 (de) | 1996-07-04 |
DE69132931T2 (de) | 2002-11-28 |
EP0681842A3 (de) | 1998-06-10 |
DE69133614D1 (de) | 2009-04-30 |
CA2093927A1 (en) | 1992-05-20 |
ATE213165T1 (de) | 2002-02-15 |
EP0995445A3 (de) | 2004-01-07 |
DK0558647T3 (da) | 1996-08-19 |
ES2090598T3 (es) | 1996-10-16 |
EP0681842B1 (de) | 2002-02-13 |
JPH11346765A (ja) | 1999-12-21 |
WO1992008985A2 (en) | 1992-05-29 |
WO1992008985A3 (en) | 1992-10-29 |
DK0681842T3 (da) | 2002-06-03 |
DE69132931D1 (de) | 2002-03-21 |
AU9106791A (en) | 1992-06-11 |
ES2324322T3 (es) | 2009-08-04 |
JP3159966B2 (ja) | 2001-04-23 |
EP0558647B1 (de) | 1996-05-29 |
AU657109B2 (en) | 1995-03-02 |
US5210017A (en) | 1993-05-11 |
JP2977280B2 (ja) | 1999-11-15 |
ATE138739T1 (de) | 1996-06-15 |
ES2171478T3 (es) | 2002-09-16 |
EP0995445B1 (de) | 2009-03-18 |
JPH06502724A (ja) | 1994-03-24 |
EP0681842A2 (de) | 1995-11-15 |
HK1007351A1 (en) | 1999-04-09 |
DE69119911T2 (de) | 1996-11-21 |
EP0558647A1 (de) | 1993-09-08 |
DK0995445T3 (da) | 2009-07-06 |
CA2093927C (en) | 2000-07-18 |
EP0995445A2 (de) | 2000-04-26 |
GR3020505T3 (en) | 1996-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69133614D1 (de) | Verwendung von IGF-1 allein oder kombiniert mit dem Wachstumsfaktor zur Stimulierung des Wachstums | |
VAN WYK et al. | Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins | |
DE60042617D1 (de) | Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2 | |
IL101728A0 (en) | Human notch and delta,binding domains in toporhythmic proteins,and methods based thereon | |
NO964650L (no) | LAG-3 proteinopploselige polypeptidfraksjoner, fremgangsmate for fremstilling, terapeutisk preparat og anti-idiotype antistoff | |
ATE140963T1 (de) | Verfahren zur herstellung von sekretierten rezeptoranalogen | |
EP0150735A3 (en) | Method and composition for preparation of factor viiic | |
IL96043A0 (en) | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known | |
Merchenthaler et al. | Immunocytochemical localization of growth hormone releasing factor (GHRF)-containing structures in the rat brain using anti-rat GHRF serum | |
ATE366420T1 (de) | Kit und verfahren zur bestimmung von protein esm- 1 | |
Corps et al. | Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin | |
CA2291983A1 (en) | Ligand-mediated immunofunctional hormone binding protein assay method | |
Carlsson et al. | Ligand-mediated immunofunctional hormone binding protein assay method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0995445 Country of ref document: EP |
|
EELA | Cancelled due to lapse of time |